Analogue na Plavix.

Daya daga hade antiplatelet far ne mai magani, "Plavix". Yau ne ma sau da yawa sosai amfani da magani, kamar wani analogue na Plavix zilt. Da miyagun ƙwayoyi abun da ke ciki hada da duka clopidogrel da acetylsalicylic acid. Babban mataki na Pharmaceutical shiri ne directed ga hanawa na ADP-tsoka mai amsa sigina da alhakin tari na jini Kwayoyin (musamman platelets). A bayãnin hukuncin siffa daga cikin shirye-shiryen da yake babu ja nauyin da ADP-rabe, wadda take kaiwa zuwa wani barga sakamako a kan tari. A sakamakon tsoka mai amsa sigina aiki ne a mayar da kawai a mutuwa da haihuwa da kuma kira na sabon platelets. Irin wannan shi ne tsarin da kuma tsarin ba da aikin na analogue na Plavix - zilta.

Clopidogrel (Plavix analogue) da ake amfani a wani sashi na 75 milligrams. A rana ta farko na shan miyagun ƙwayoyi nuna wani gagarumin attenuation na platelet tari aiki. Bayan m aikace-aikace na mai magani sakamako ƙaruwa. Sa'a da'ira Pharmaceutical shiri ne da matsakaita na uku zuwa kwana bakwai. Bayan an daina miyagun ƙwayoyi sakamako shi ne kiyaye (ba cikakken sabunta har mafi yawan platelet abun da ke ciki) ga wani lokaci na biyar zuwa bakwai kwanaki.

Salicylic acid sa hanawa na platelet tari saboda babu ja hanawa na cyclooxygenase (Cox-1). Kamar yadda wani sakamako, rage thromboxane kira da attenuated vasoconstriction. Kamar yadda a yanayin saukan clopidogrel jawo sakamako ne kiyaye a kan rayuwa na jini Kwayoyin (platelets).

Me amfani da wani analogue na Plavix da miyagun ƙwayoyi da kanta? Mafi na kowa yin amfani da hade antiplatelet far da aka kubutar a babban hadarin da jijiyoyin bugun gini thrombosis na wani wuri, a gaban atherosclerotic raunuka.

Akwai daya mafi m analogue na Plavix - listab. Duk da haka, ya, kamar mutane da yawa wasu (klopilet, lopirel, plargil, detromb, plogrel, Trocken, kardutol), ba a yi amfani da ko'ina a cikin zamani likita yi.

Plavix ko zilt?

Mai likitoci jingina zuwa ga yin amfani da Plavix, tun ingancinta an tabbatar da yi da ka gwaji. Evidence tushe da miyagun ƙwayoyi ya samu da baya a shekarar 2007 da kuma a cikin past shekaru biyar, da aiki da yin amfani da kawai ƙarfafa suna da "mafi kyau samfurin". Amma zilta, ta yadda ya dace, kamar yadda muka gani da likitoci da kansu, da ɗan ƙananan fiye da ayyana, don haka idan aka kwatanta da ta takwaransa a game da ingancin magani ya iya ba. Ainihi, masana kimiyya yi imani da cewa low yadda ya dace da karshen ne saboda da ajizanci na fasaha aiwatar da Manufacturing da miyagun ƙwayoyi. Biophysics guda lura da wasu, sãɓã wa jũnamai a kwayoyin tsarin tsakanin Plavix kuma ta analogue.

Amma ga farashin, shi muhimmanci hasarar Plavix ziltu. Saboda haka, farashin na farko sau uku da tamanin da biyu. A lokuta da dama, da kudin da miyagun ƙwayoyi take kaiwa zuwa da bukatar yin amfani da kasa aiki takwarorinsu. A kan tabbacin likitoci na zamani kananan dakunan shan magani, idan ba za ka iya saya da tsada Plavix kamata ba saya mai rahusa analogue daga gare - zilt. Gaba daya watsi da m da miyagun ƙwayoyi ba da shawarar.

Kamar yadda irin wannan magani kamar yadda "Ko Plavix," to, shi ne mai hallmark na wani ƙara sashi na wani ɓangare na gyara (100 da kuma 75 MG na salicylic acid, kuma clopidogrel, bi da bi).

Abin baƙin ciki, to date masana'antu da fasaha "Plavix" medicament, kazalika da ta bijiro da batun kafa gyara su ne quite tsada, wadda take kaiwa zuwa babban kudin magani. A amfani da taimakon m marasa lafiya zo da kyau analogues na iri-sunan kwayoyi.